Safety Study of PI-0824 to Treat Pemphigus Vulgaris
NCT00063752 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2005-06-24
Summary
The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.
Conditions
- Pemphigus Vulgaris
Interventions
- DRUG
-
PI-0824
Sponsors & Collaborators
-
Peptimmune
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-07-31
- Completion
- 2005-03-31
Countries
- United States
Study Locations
More Related Trials
-
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)
NCT06305234 ·Status: RECRUITING
-
rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
NCT04035733 ·Status: COMPLETED ·Phase: PHASE2
-
Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid
NCT00802243 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Tildrakizumab in Treatment of Bullous Pemphigoid
NCT04465292 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
NCT04206553 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Safety and Tolerability of INCB050465 in Pemphigus Vulgaris
NCT03780166 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Clinical Study of B007 in the Treatment of Pemphigus.
NCT06454357 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
NCT04598477 ·Status: TERMINATED ·Phase: PHASE3
-
Rituximab in the Treatment of Patients With Bullous Pemphigoid
NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus
NCT00483119 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment
NCT01688882 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris
NCT01920477 ·Status: TERMINATED ·Phase: PHASE3
-
Exploratory Study of IFX-1 in Patients With Pyoderma Gangrenosum
NCT03971643 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris
NCT04023149 ·Status: UNKNOWN ·Phase: PHASE2
-
A Safety and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
NCT03075904 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler Syndrome
NCT04213274 ·Status: WITHDRAWN ·Phase: PHASE2
-
Long-Term Extension Study of Ofatumumab in Subjects With Pemphigus Vulgaris
NCT02613910 ·Status: TERMINATED ·Phase: PHASE3
-
An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
NCT02315417 ·Status: TERMINATED ·Phase: PHASE3
-
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis
NCT00001761 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, PD, PK and Efficacy of ARGX-113 in Patients With Pemphigus
NCT03334058 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.
NCT06663943 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Anti-IL-5 Therapy in Bullous Pemphigoid (BP)
NCT01705795 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
NCT04128176 ·Status: WITHDRAWN ·Phase: PHASE3
-
Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus
NCT04117529 ·Status: UNKNOWN ·Phase: NA
-
Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy
NCT05138757 ·Status: COMPLETED ·Phase: PHASE1/PHASE2